日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical Trial

PF-07038124治疗特应性皮炎和斑块状银屑病患者的疗效和安全性:一项随机临床试验

Eichenfield, Lawrence F; Tarabar, Sanela; Forman, Seth; García-Bello, Alfonso; Feng, Gang; Fetterly, Gerald; Mahling, Ping; Peeva, Elena; Vincent, Michael S; Chandra, Deepa E

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients

FGFR/VEGFR抑制剂多维替尼联合吉西他滨和卡培他滨治疗晚期实体瘤和胰腺癌患者的Ib期研究

Ma, Wen Wee; Xie, Hao; Fetterly, Gerald; Pitzonka, Laura; Whitworth, Amy; LeVea, Charles; Wilton, John; Mantione, Krystin; Schihl, Sarah; Dy, Grace K; Boland, Patrick; Iyer, Renuka; Tan, Wei; Brady, William; Straubinger, Robert M; Adjei, Alex A

A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies

一项针对晚期恶性肿瘤患者的静脉注射帕立骨化醇联合吉西他滨的1期开放标签剂量递增研究

Fountzilas, Christos; Javle, Milind; Tan, Wei; Ma, Yingyu; Fetterly, Gerald; Iyer, Renuka; Johnson, Candace

Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model

Apo2L/TRAIL介导的肿瘤预处理可降低间质液压力,并增强脂质体吉西他滨在患者来源的异种移植瘤模型中的疗效。

Hylander, Bonnie L; Sen, Arindam; Beachy, Sarah H; Pitoniak, Rose; Ullas, Soumya; Gibbs, John F; Qiu, Jingxin; Prey, Joshua D; Fetterly, Gerald J; Repasky, Elizabeth A

A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers

一项比较亚麻籽、芳香化酶抑制剂及其联合用药对乳腺肿瘤生物标志物影响的初步研究

McCann, Susan E; Edge, Stephen B; Hicks, David G; Thompson, Lilian U; Morrison, Carl D; Fetterly, Gerald; Andrews, Christopher; Clark, Kim; Wilton, John; Kulkarni, Swati

Interactions of everolimus and sorafenib in pancreatic cancer cells

依维莫司和索拉非尼在胰腺癌细胞中的相互作用

Pawaskar, Dipti K; Straubinger, Robert M; Fetterly, Gerald J; Ma, Wen W; Jusko, William J

Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia

建立临床前PK/PD模型以评估阿柏西普和多柔比星序贯给药策略在急性髓系白血病中的抗肿瘤反应

Fetterly, Gerald J; Aras, Urvi; Lal, Deepika; Murphy, Michael; Meholick, Patricia D; Wang, Eunice S

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer

一项针对骨转移去势抵抗性前列腺癌男性患者的KX2-391(一种口服Src激酶和微管蛋白聚合抑制剂)的II期研究

Antonarakis, Emmanuel S; Heath, Elisabeth I; Posadas, Edwin M; Yu, Evan Y; Harrison, Michael R; Bruce, Justine Y; Cho, Steve Y; Wilding, Gregory E; Fetterly, Gerald J; Hangauer, David G; Kwan, Min-Fun R; Dyster, Lyn M; Carducci, Michael A

Physiologically based pharmacokinetic models for everolimus and sorafenib in mice

小鼠体内依维莫司和索拉非尼的生理药代动力学模型

Pawaskar, Dipti K; Straubinger, Robert M; Fetterly, Gerald J; Hylander, Bonnie H; Repasky, Elizabeth A; Ma, Wen W; Jusko, William J

Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice

索拉非尼与依维莫司在小鼠胰腺癌异种移植模型中的协同作用

Pawaskar, Dipti K; Straubinger, Robert M; Fetterly, Gerald J; Hylander, Bonnie H; Repasky, Elizabeth A; Ma, Wen W; Jusko, William J